| Ophthalmic Consultants Of Connecticut Pc | |
|
1375 Kings Hwy, Fairfield, CT 06824-5318 | |
| (203) 366-8000 | |
| Not Available |
| Full Name | Ophthalmic Consultants Of Connecticut Pc |
|---|---|
| Type | Facility |
| Speciality | Ophthalmology |
| Location | 1375 Kings Hwy, Fairfield, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659319598 | NPI | - | NPPES |
| 001411553 | Medicaid | CT | |
| 004226115 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 002247 (Connecticut) | Secondary |
| 207W00000X | Ophthalmology | 041155 (Connecticut) | Primary |
| Provider Name | Scott M Soloway |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1831282607 PECOS PAC ID: 2961444377 Enrollment ID: I20050525001169 |
News Archive
Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.
It was only recently that Griffith University research showed that it's possible to improve the hydrating effects of beer without killing off its taste.
According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.
A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.
› Verified 5 days ago
| Provider Name | Michael P Goldstein |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1013003615 PECOS PAC ID: 7517022726 Enrollment ID: I20090220000535 |
News Archive
Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.
It was only recently that Griffith University research showed that it's possible to improve the hydrating effects of beer without killing off its taste.
According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.
A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.
› Verified 5 days ago
| Provider Name | James F Martone |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1649242603 PECOS PAC ID: 0446348486 Enrollment ID: I20091125000118 |
News Archive
Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.
It was only recently that Griffith University research showed that it's possible to improve the hydrating effects of beer without killing off its taste.
According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.
A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.
› Verified 5 days ago
| Provider Name | Anish U Shah |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1528092657 PECOS PAC ID: 3779669189 Enrollment ID: I20091208000470 |
News Archive
Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.
It was only recently that Griffith University research showed that it's possible to improve the hydrating effects of beer without killing off its taste.
According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.
A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.
› Verified 5 days ago
| Provider Name | Peter S Mckay |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1235163361 PECOS PAC ID: 7416033824 Enrollment ID: I20091208000677 |
News Archive
Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.
It was only recently that Griffith University research showed that it's possible to improve the hydrating effects of beer without killing off its taste.
According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.
A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.
› Verified 5 days ago
| Provider Name | Ronald W Slocumb |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1699893545 PECOS PAC ID: 8628121357 Enrollment ID: I20100816000823 |
News Archive
Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.
It was only recently that Griffith University research showed that it's possible to improve the hydrating effects of beer without killing off its taste.
According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.
A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.
› Verified 5 days ago
| Provider Name | Joseph J Thimons |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1851371454 PECOS PAC ID: 1254305832 Enrollment ID: I20110203000760 |
News Archive
Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.
It was only recently that Griffith University research showed that it's possible to improve the hydrating effects of beer without killing off its taste.
According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.
A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.
› Verified 5 days ago
| Provider Name | Jonathan J Stein |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1881636793 PECOS PAC ID: 0143400168 Enrollment ID: I20110209000008 |
News Archive
Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.
It was only recently that Griffith University research showed that it's possible to improve the hydrating effects of beer without killing off its taste.
According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.
A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.
› Verified 5 days ago
| Provider Name | Robert Noecker |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1588638217 PECOS PAC ID: 8527957570 Enrollment ID: I20110519000160 |
News Archive
Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.
It was only recently that Griffith University research showed that it's possible to improve the hydrating effects of beer without killing off its taste.
According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.
A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.
› Verified 5 days ago
| Provider Name | Eric D Donnenfeld |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1891790770 PECOS PAC ID: 9436246170 Enrollment ID: I20110930000230 |
News Archive
Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.
It was only recently that Griffith University research showed that it's possible to improve the hydrating effects of beer without killing off its taste.
According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.
A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.
› Verified 5 days ago
| Provider Name | David Cartwright |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1578979258 PECOS PAC ID: 0749581031 Enrollment ID: I20151210000425 |
News Archive
Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.
It was only recently that Griffith University research showed that it's possible to improve the hydrating effects of beer without killing off its taste.
According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.
A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.
› Verified 5 days ago
| Provider Name | Emily Love |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1215319165 PECOS PAC ID: 7113205527 Enrollment ID: I20161104001133 |
News Archive
Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.
It was only recently that Griffith University research showed that it's possible to improve the hydrating effects of beer without killing off its taste.
According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.
A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.
› Verified 5 days ago
| Provider Name | Kinneri K Kothari |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1588084446 PECOS PAC ID: 5698079424 Enrollment ID: I20180830000288 |
News Archive
Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.
It was only recently that Griffith University research showed that it's possible to improve the hydrating effects of beer without killing off its taste.
According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.
A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.
› Verified 5 days ago
| Provider Name | Himakshi N Bhatt |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1356913347 PECOS PAC ID: 1759764236 Enrollment ID: I20220816002212 |
News Archive
Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.
It was only recently that Griffith University research showed that it's possible to improve the hydrating effects of beer without killing off its taste.
According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.
A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.
› Verified 5 days ago
| Provider Name | Laura Tiedemann |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1346745775 PECOS PAC ID: 1254728546 Enrollment ID: I20230717002505 |
News Archive
Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.
It was only recently that Griffith University research showed that it's possible to improve the hydrating effects of beer without killing off its taste.
According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.
A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ophthalmic Consultants Of Connecticut Pc 825 E Gate Blvd Ste 111, Garden City, NY 11530-2136 Ph: (516) 804-5200 | Ophthalmic Consultants Of Connecticut Pc 1375 Kings Hwy, Fairfield, CT 06824-5318 Ph: (203) 366-8000 |
News Archive
Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.
It was only recently that Griffith University research showed that it's possible to improve the hydrating effects of beer without killing off its taste.
According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.
A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.
› Verified 5 days ago